Vanda Pharmaceuticals (VNDA) Gross Profit Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.03% |
| Dec 31, 2025 | -2.71% |
| Sep 30, 2025 | -0.41% |
| Jun 30, 2025 | -2.42% |
| Mar 31, 2025 | -2.50% |
| Dec 31, 2024 | -1.55% |
| Sep 30, 2024 | -3.07% |
| Jun 30, 2024 | -1.95% |
| Mar 31, 2024 | 0.66% |
| Dec 31, 2023 | -2.47% |
| Sep 30, 2023 | -4.10% |
| Jun 30, 2023 | 0.20% |
| Mar 31, 2023 | 8.14% |
| Dec 31, 2022 | 8.08% |
| Sep 30, 2022 | 9.89% |
| Jun 30, 2022 | 9.22% |
| Mar 31, 2022 | 10.29% |
| Dec 31, 2021 | 13.38% |
| Sep 30, 2021 | 14.98% |
| Jun 30, 2021 | 15.74% |
| Mar 31, 2021 | 15.71% |
| Dec 31, 2020 | 18.99% |
| Sep 30, 2020 | 20.04% |
| Jun 30, 2020 | 20.90% |
| Mar 31, 2020 | 25.24% |
| Dec 31, 2019 | 30.08% |
| Sep 30, 2019 | 30.21% |
| Jun 30, 2019 | 37.65% |
| Dec 31, 2015 | 49.02% |
| Sep 30, 2015 | 24.68% |
| Jun 30, 2015 | 284.38% |